StockNews.com cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a buy rating to a hold rating in a research note released on Tuesday. Separately, Bank of America began coverage on shares of Amphastar Pharmaceuticals in a research note on Friday, November 17th. They set a neutral rating and a $63.00 price objective on […]
StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a research note released on Friday morning. Separately, Bank of America started coverage on Amphastar Pharmaceuticals in a research note on Friday, November 17th. They issued a neutral rating and a $63.00 price objective on the […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $61.37, for a total transaction of $30,685.00. Following the sale, the director now owns 80,833 shares in the […]